\r\n This is a rare opportunity to acquire a highly profitable, owner-operated Italian restaurant that has been a cornerstone of its Long Island community for over 50 years. Established in 1972, the restaurant has built a stellar reputation for authentic Italian cuisine, loyal clientele, and consistent financial performance.

\r\n Generating over $3.5 million in annual gross revenue and approximately $700,000 in bottom-line profit, this business represents a turnkey, high-cash-flow opportunity for an experienced operator or restaurateur looking to step into an established, proven concept.

\r\n The restaurant features a full kitchen, upscale dining environment, and the operational infrastructure necessary to support continued growth. Known for its traditional Italian menu offerings—including handmade pastas, fresh seafood, and classic meat dishes—the establishment has maintained its reputation through decades of consistent quality and service.

\r\n This business has been primarily owner-operated, and a hands-on owner with strong operational experience could potentially increase profitability even further through cost optimization, expanded hours, catering growth, or enhanced marketing initiatives.

\r\n Key Highlights:

\r\n • Established over 50 years with exceptional brand recognition and loyal customer base
\r\n • $3.5M+ in annual revenue with approximately $700K net profit
\r\n • Fully built-out, turnkey operation with experienced staff and proven systems

\r\n This is an ideal acquisition for an experienced restaurant operator, hospitality group, or investor seeking a stable, high-income business with a long operating history and significant goodwill.

\r\n Serious inquiries only. Proof of funds required.

\r\n This is a rare opportunity to acquire a fully credentialed clinical medical laboratory in its early growth stage, strategically positioned to scale to $4–$5 million in annual revenue within the next 24 months under focused business development and payer expansion.

\r\n Importantly, this is not a startup concept — it is an operational, credentialed lab platform. The infrastructure, licensing, equipment, and compliance foundation are already in place. Replicating this build-out from scratch would conservatively exceed $4 million in capital investment, making this a true replacement-cost opportunity with substantial upside.

\r\n Business Overview

\r\n This clinical laboratory provides a wide range of diagnostic testing services used by healthcare providers to diagnose, monitor, and screen for health conditions. The lab is:

• \r\n
• \r\n

  \r\n Registered with an active NPI (National Provider Identifier)

  \r\n \r\n
• \r\n

  \r\n Operating under CLIA certification

  \r\n \r\n
• \r\n

  \r\n Approved to perform regulated clinical laboratory testing

  \r\n \r\n

\r\n The platform is structured for expansion, not stabilization — presenting a growth-oriented acquisition opportunity.

\r\n Services & Capabilities

\r\n The lab currently offers a broad testing menu, including:

• \r\n
• \r\n

  \r\n Genetic and molecular diagnostics

  \r\n \r\n
• \r\n

  \r\n Routine clinical testing

  \r\n \r\n
• \r\n

  \r\n Clinical toxicology

  \r\n \r\n
• \r\n

  \r\n Allergy testing

  \r\n \r\n
• \r\n

  \r\n COVID-19 testing

  \r\n \r\n

\r\n Regulatory listings allow testing across multiple disciplines, including:

• \r\n
• \r\n

  \r\n Bacteriology

  \r\n \r\n
• \r\n

  \r\n Clinical chemistry

  \r\n \r\n
• \r\n

  \r\n Immunology (serology)

  \r\n \r\n
• \r\n

  \r\n Endocrinology

  \r\n \r\n
• \r\n

  \r\n Hematology

  \r\n \r\n
• \r\n

  \r\n Toxicology

  \r\n \r\n
• \r\n

  \r\n Urinalysis

  \r\n \r\n
• \r\n

  \r\n Virology

  \r\n \r\n

\r\n This diversified testing capability supports scalability across multiple provider verticals.

\r\n Clinical Credentials

\r\n The laboratory team includes:

• \r\n
• \r\n

  \r\n Board-certified pathologists

  \r\n \r\n
• \r\n

  \r\n Ph.D.-level professionals with credentials in molecular diagnostics

  \r\n \r\n
• \r\n

  \r\n Qualified clinical laboratory personnel

  \r\n \r\n

\r\n The lab emphasizes competitive turnaround times and flexible provider ordering/reporting systems, creating a scalable provider-facing platform.

\r\n Location & Market

\r\n Located in Central New Jersey, servicing healthcare providers throughout New York and New Jersey — two of the most regulated and high-value healthcare markets in the country.

\r\n Growth Opportunity- ASSET SALE

\r\n This lab is in its infancy operationally but fully built structurally. Key growth drivers include:

• \r\n
• \r\n

  \r\n Expansion of provider network

  \r\n \r\n
• \r\n

  \r\n Increased specimen volume

  \r\n \r\n
• \r\n

  \r\n Strategic payer contracting

  \r\n \r\n
• \r\n

  \r\n Sales force deployment

  \r\n \r\n
• \r\n

  \r\n Targeted specialty testing expansion

  \r\n \r\n

\r\n With proper capitalization and business development, the platform is positioned for significant near-term revenue growth.

\r\n Ideal Buyer

• \r\n
• \r\n

  \r\n Strategic laboratory operators

  \r\n \r\n
• \r\n

  \r\n Healthcare investors

  \r\n \r\n
• \r\n

  \r\n Private equity groups

  \r\n \r\n
• \r\n

  \r\n Physician groups seeking vertical integration

  \r\n \r\n
• \r\n

  \r\n Healthcare consolidators

  \r\n \r\n

\r\n Confidential offering. Financials, payer mix, equipment schedules, and regulatory documentation available upon NDA.